EVGN (Evogene) Short Interest


EVGN Evogene Ltd EVGN
33 GF Score
Price $0.40
GF Value $0.40
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Evogene Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

EVGN vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, Evogene's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Evogene Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Evogene's Short Interest distribution charts can be found below:

* The bar in red indicates where Evogene's Short Interest falls into.


EVGN
33GF Score
Evogene Ltd EVGN
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Evogene (EVGN) Overvalued in 2026?

Based on GuruFocus' analysis, Evogene stock appears to be undervalued. The current stock price of $0.40 is trading 0.5% below its estimated GF Value™ of $0.40. GuruFocus considers Evogene to be Fairly Valued.

Key valuation signals for EVGN:

  • Short Interest:
  • GF Value™: $0.40 vs. price of $0.40 (0.5% below fair value)
  • GF Score™: 33/100 with 7 warning signs

No single metric tells the full story. See the EVGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Evogene Business Description

Other Exchanges EVGN:Israel
Address 13 Gad Feinstein Street, Park Rehovot, Ness Ziona, Rehovot, ISR, 7638517
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.
33GF Score

Get the complete analysis for EVGN

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.40
Price
$0.40
GF Value